Discover what healthcare professionals are saying about the latest therapies, drugs, and biotech innovations. Elucidate Life Sciences is the platform for biotech & life science investors seeking a competitive edge using advanced analytics to provide real-time insights into the clinician and researcher conversations.
Leverage the collective intelligence of the medical community and zero-in on key opinion leaders' perspectives to make data-driven investment choices
Identify investment opportunities early through real-time monitoring of medical expert discussions.
Understand the risks associated with therapies from a clinical perspective.
Deepen your investment research with insights derived from healthcare professionals' real-world experiences and opinions
Elucidate aggregates millions of publicly available conversations from health care professionals, clinicians and researchers from platforms, including podcasts, Twitter, and Substack.
Elucidate Life Sciences employs advanced natural language processing (NLP) algorithms and Generative AI to extract relevant information, sentiment, and trends from conversations. Machine learning models identify patterns, correlations, and emerging themes in therapeutic discussions, enabling the platform to predict trends and provide early signals of shifts in medical practices.
Access leading indicator conversations providing early signals of therapeutic decision-making.
Data available
since 2021
Podcasts from
HCPs indexed
Unique HCP Sources
HCP Conversations
While Elucidate Life Sciences is in beta we're offering special beta pricing as well as a 14 day free trial to give you a chance to check it out
$249/m
$999/m
